I’m hoping that IDT gets to produce Novavax vaccine which will realise short term revenue and manufacturing mRNA vaccines is longer term, more than 18 months away.
I wonder if they get a contract to produce say 50 million Novavax per year for 2 or 3 years could they borrow against that to make up their contribution of setting up the facility. If they can do that maybe don’t need a capital raise.
I’m hoping that IDT gets to produce Novavax vaccine which will...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
